Can sugarcoated fingerprints be used to identify lurking viruses?

Research output: Contribution to journalComment/debate

Abstract

Comparative proteomics is increasingly used to detect biomarkers and therapeutic targets that differ between healthy and diseased populations; however, differences in posttranslational modifications have received less attention. In this issue, Yang et al. (Proteomics 2016, 16, 1872–1880) present data indicating that a glycoproteomics approach can detect N-glycosylated membrane protein differences between non-HIV-infected and latently infected human CD4+ T-cell lines, identifying 172 proteins differentially expressed by these cells. Latently infected CD4+ T cells are thought to represent the major barrier to eventual HIV cure, but do not express detectable levels of viral protein and have not been shown to express biomarkers that can distinguish them from the vastly more abundant uninfected CD4+ T-cell population. The findings of Yang et al. suggest that glycoproteomic analyses may have untapped potential to identify novel biomarkers and therapeutic targets in cell populations not readily distinguishable be standard proteomic analyses.

Original languageEnglish (US)
Pages (from-to)1947-1948
Number of pages2
JournalProteomics
Volume16
Issue number13
DOIs
StatePublished - Jul 1 2016
Externally publishedYes

Fingerprint

Dermatoglyphics
Biomarkers
Viruses
Proteomics
T-cells
Population
T-Lymphocytes
Viral Proteins
Post Translational Protein Processing
Membrane Proteins
Cells
HIV
Cell Line
Therapeutics
Proteins

Keywords

  • Comparative glycoproteomics
  • Glycoproteomics
  • HIV-1 latency
  • N-glycoslylation

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

Can sugarcoated fingerprints be used to identify lurking viruses? / Hu, Ye.

In: Proteomics, Vol. 16, No. 13, 01.07.2016, p. 1947-1948.

Research output: Contribution to journalComment/debate

@article{087b0b5480aa4d2cb5ca6f6245300d0f,
title = "Can sugarcoated fingerprints be used to identify lurking viruses?",
abstract = "Comparative proteomics is increasingly used to detect biomarkers and therapeutic targets that differ between healthy and diseased populations; however, differences in posttranslational modifications have received less attention. In this issue, Yang et al. (Proteomics 2016, 16, 1872–1880) present data indicating that a glycoproteomics approach can detect N-glycosylated membrane protein differences between non-HIV-infected and latently infected human CD4+ T-cell lines, identifying 172 proteins differentially expressed by these cells. Latently infected CD4+ T cells are thought to represent the major barrier to eventual HIV cure, but do not express detectable levels of viral protein and have not been shown to express biomarkers that can distinguish them from the vastly more abundant uninfected CD4+ T-cell population. The findings of Yang et al. suggest that glycoproteomic analyses may have untapped potential to identify novel biomarkers and therapeutic targets in cell populations not readily distinguishable be standard proteomic analyses.",
keywords = "Comparative glycoproteomics, Glycoproteomics, HIV-1 latency, N-glycoslylation",
author = "Ye Hu",
year = "2016",
month = "7",
day = "1",
doi = "10.1002/pmic.201600197",
language = "English (US)",
volume = "16",
pages = "1947--1948",
journal = "Proteomics",
issn = "1615-9853",
publisher = "Wiley-VCH Verlag",
number = "13",

}

TY - JOUR

T1 - Can sugarcoated fingerprints be used to identify lurking viruses?

AU - Hu, Ye

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Comparative proteomics is increasingly used to detect biomarkers and therapeutic targets that differ between healthy and diseased populations; however, differences in posttranslational modifications have received less attention. In this issue, Yang et al. (Proteomics 2016, 16, 1872–1880) present data indicating that a glycoproteomics approach can detect N-glycosylated membrane protein differences between non-HIV-infected and latently infected human CD4+ T-cell lines, identifying 172 proteins differentially expressed by these cells. Latently infected CD4+ T cells are thought to represent the major barrier to eventual HIV cure, but do not express detectable levels of viral protein and have not been shown to express biomarkers that can distinguish them from the vastly more abundant uninfected CD4+ T-cell population. The findings of Yang et al. suggest that glycoproteomic analyses may have untapped potential to identify novel biomarkers and therapeutic targets in cell populations not readily distinguishable be standard proteomic analyses.

AB - Comparative proteomics is increasingly used to detect biomarkers and therapeutic targets that differ between healthy and diseased populations; however, differences in posttranslational modifications have received less attention. In this issue, Yang et al. (Proteomics 2016, 16, 1872–1880) present data indicating that a glycoproteomics approach can detect N-glycosylated membrane protein differences between non-HIV-infected and latently infected human CD4+ T-cell lines, identifying 172 proteins differentially expressed by these cells. Latently infected CD4+ T cells are thought to represent the major barrier to eventual HIV cure, but do not express detectable levels of viral protein and have not been shown to express biomarkers that can distinguish them from the vastly more abundant uninfected CD4+ T-cell population. The findings of Yang et al. suggest that glycoproteomic analyses may have untapped potential to identify novel biomarkers and therapeutic targets in cell populations not readily distinguishable be standard proteomic analyses.

KW - Comparative glycoproteomics

KW - Glycoproteomics

KW - HIV-1 latency

KW - N-glycoslylation

UR - http://www.scopus.com/inward/record.url?scp=84990222922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990222922&partnerID=8YFLogxK

U2 - 10.1002/pmic.201600197

DO - 10.1002/pmic.201600197

M3 - Comment/debate

C2 - 27297056

AN - SCOPUS:84990222922

VL - 16

SP - 1947

EP - 1948

JO - Proteomics

JF - Proteomics

SN - 1615-9853

IS - 13

ER -